Phoenix Solutions AS announced the appointments to its Board of Directors. Sir William (Bill) Castell has been appointed Vice Chairman of the Board and Dr. Masha Stromme, a Phoenix Director since 2015, has been appointed Chairman, both effective since June 22, 2018. Jan Fikkan who was instrumental in the establishment of Phoenix since it was spun out of GE Healthcare in 2012, is stepping down as Chairman of the Board and will remain a Director of the Board. Bill was President and Chief Executive Officer of GE Healthcare and biosciences business of the General Electric Company, of which he was also a Vice Chairman. He was Chief Executive of Amersham plc which was acquired by GE Healthcare in 2004. Bill retired as a Director of the General Electric Company in April 2011. From 2006 to 2012 he served as a non-executive director, and latterly senior independent director, of BP plc. From 2006 until his retirement in 2015, he held the very prestigious position of Chairman of the Wellcome Trust. Masha has over 20 years of experience in Healthcare. She has been involved in leading the first financings of Phoenix Solutions AS where she has been a director since 2015. Masha started her career in Investment Banking at Morgan Stanley in London in 1998, focusing on Biotechnology. As a research analyst at Altium Capital (Apax, London), she covered the Biotech and Medtech stocks for the UK and Europe. She has worked as an advisor to Arctic Securities and to Norway Healthtech to stimulate a flow of private capital to the Norwegian Healthcare sector. She is an experienced healthcare investor, board member and co-founder of Fortuna Fix – a regenerative medicine company. She is responsible for corporate development at Fortuna.